
VolitionRx Limited VNRX
$ 0.19
6.81%
Quarterly report 2025-Q3
added 11-13-2025
Country |
|
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NYSE AMERICAN |
Shares |
96.1 M |
Market Cap[1] |
$ 18.3 M |
EBITDA (LTM) |
$ -29.5 M |
P/E (LTM) |
-0.43 |
P/S (LTM) |
10.4 |
EPS (LTM) |
-0.44 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.7 | - | $ 7.46 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 123.89 | -0.35 % | $ 19.7 B | Nasdaq Global Select Market,SPB | ||
|
Biomerica
BMRA
|
$ 2.18 | -0.46 % | $ 5.01 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 13.71 | 0.37 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Lantheus Holdings
LNTH
|
$ 76.52 | 0.11 % | $ 5.16 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 457.91 | 1.19 % | $ 13.2 B | Nasdaq Global Select Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 104.91 | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 239.14 | 2.92 % | $ 25.5 B | NYSE,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.72 | 2.95 % | $ 437 M | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 3.58 | 3.77 % | $ 1.92 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 8.19 | 2.89 % | $ 1.05 B | Nasdaq Global Select Market,SPB | ||
|
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
National Research Corporation
NRC
|
$ 17.24 | -0.46 % | $ 386 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 201.25 | 3.06 % | $ 19.8 B | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
OPKO Health
OPK
|
$ 1.13 | 0.45 % | $ 784 M | Nasdaq Global Select Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 156.34 | 1.84 % | $ 7.75 B | NYSE,SPB | ||
|
IQVIA Holdings
IQV
|
$ 167.44 | 0.81 % | $ 28.8 B | NYSE,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Personalis
PSNL
|
$ 7.68 | 5.72 % | $ 455 M | Nasdaq Global Select Market | ||
|
IDEXX Laboratories
IDXX
|
$ 584.21 | 1.2 % | $ 47 B | Nasdaq Global Select Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.33 | 15.22 % | $ 1.69 M | Nasdaq Capital Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 6.68 | 3.09 % | $ 279 M | NYSE American | ||
|
Agilent Technologies
A
|
$ 112.35 | 0.97 % | $ 34.2 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 101.9 | 2.2 % | $ 8.4 B | Nasdaq Global Select Market,SPB | ||
|
Sotera Health Company
SHC
|
$ 14.05 | 4.07 % | $ 3.99 B | Nasdaq Global Select Market | ||
|
DarioHealth Corp.
DRIO
|
$ 7.99 | - | $ 31.8 M | Nasdaq Capital Market | ||
|
Guardant Health
GH
|
$ 86.87 | 1.98 % | $ 10.9 B | Nasdaq Global Select Market,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 32.53 | -2.06 % | $ 1.65 B | Nasdaq Capital Market | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Neuronetics
STIM
|
$ 1.58 | 9.07 % | $ 104 M | Nasdaq Global Select Market | ||
|
Thermo Fisher Scientific
TMO
|
$ 481.04 | 1.37 % | $ 181 B | NYSE,SPB | ||
|
CareDx, Inc
CDNA
|
$ 17.61 | 2.68 % | $ 938 M | Nasdaq Global Market,SPB | ||
|
Bioventus
BVS
|
$ 8.95 | 3.59 % | $ 596 M | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 107.58 | 1.45 % | $ 4.24 B | Nasdaq Global Select Market | ||
|
Trinity Biotech plc
TRIB
|
$ 0.64 | 0.53 % | $ 61.9 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.